{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8957748", "DateCompleted": {"Year": "1997", "Month": "03", "Day": "06"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0391-4097", "JournalIssue": {"Volume": "19", "Issue": "9", "PubDate": {"Year": "1996", "Month": "Oct"}}, "Title": "Journal of endocrinological investigation", "ISOAbbreviation": "J Endocrinol Invest"}, "ArticleTitle": "Further studies on the mechanism of the mineralocorticoid action of licorice in humans.", "Pagination": {"StartPage": "624", "EndPage": "629", "MedlinePgn": "624-9"}, "Abstract": {"AbstractText": ["The pathogenesis of pseudohyperaldosteronism from licorice has been evaluated in 6 male volunteers taking daily 7 g of a commercial preparation of licorice for 7 days, corresponding to an intake of 500 mg/day of glycyrrhizic acid. Pseudohyperaldosteronism was evident during the treatment (increase of body weight, suppression of plasma renin activity and plasma aldosterone, reduction of serum potassium). The ratio (tetrahydrocortisol + allo tetrahydrocortisol)/tetrahydrocortisone in urine increased in 5 cases after 3 days of treatment, without an increase of plasma mineralocorticoid activity (PMA). In the 6th case the urinary ratio was unchanged and PMA increased from the pretreatment value. After 7 days of therapy the ratio remained high and PMA was not measurable in 3 cases, while in the other 3 cases the ratio returned to pretreatment and PMA was higher than pretreatment value. We conclude that the pseudohyperaldosteronism from licorice is initially related to decreased activity of 11 beta-hydroxysteroid-dehydrogenase and afterwards also a direct effect of licorice derivatives on mineralocorticoid receptors becomes evident in some cases. In other cases however the effect on the enzyme is prevailing probably due to individual factors."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istituto Semeiotica Medica, University of Padova, Italy."}], "LastName": "Armanini", "ForeName": "D", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lewicka", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Pratesi", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Scali", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zennaro", "ForeName": "M C", "Initials": "MC"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zovato", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gottardo", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Simoncini", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Spigariol", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zampollo", "ForeName": "V", "Initials": "V"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "J Endocrinol Invest", "NlmUniqueID": "7806594", "ISSNLinking": "0391-4097"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Mineralocorticoids"}, {"RegistryNumber": "13489-75-3", "NameOfSubstance": "tetrahydroaldosterone"}, {"RegistryNumber": "4964P6T9RB", "NameOfSubstance": "Aldosterone"}, {"RegistryNumber": "5HF9TM2D15", "NameOfSubstance": "Tetrahydrocortisone"}, {"RegistryNumber": "6FO62043WK", "NameOfSubstance": "Glycyrrhizic Acid"}, {"RegistryNumber": "7P2O6MFN8O", "NameOfSubstance": "Tetrahydrocortisol"}, {"RegistryNumber": "EC 1.1.-", "NameOfSubstance": "Hydroxysteroid Dehydrogenases"}, {"RegistryNumber": "EC 1.1.1.146", "NameOfSubstance": "11-beta-Hydroxysteroid Dehydrogenases"}, {"RegistryNumber": "EC 3.4.23.15", "NameOfSubstance": "Renin"}, {"RegistryNumber": "P540XA09DR", "NameOfSubstance": "Glycyrrhetinic Acid"}, {"RegistryNumber": "RWP5GA015D", "NameOfSubstance": "Potassium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "11-beta-Hydroxysteroid Dehydrogenases"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["analogs & derivatives", "blood", "urine"], "DescriptorName": "Aldosterone"}, {"QualifierName": ["administration & dosage", "adverse effects", "analogs & derivatives"], "DescriptorName": "Glycyrrhetinic Acid"}, {"QualifierName": [], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": [], "DescriptorName": "Glycyrrhizic Acid"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hydroxysteroid Dehydrogenases"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Hyperaldosteronism"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["blood"], "DescriptorName": "Mineralocorticoids"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["blood"], "DescriptorName": "Potassium"}, {"QualifierName": ["blood"], "DescriptorName": "Renin"}, {"QualifierName": ["urine"], "DescriptorName": "Tetrahydrocortisol"}, {"QualifierName": ["urine"], "DescriptorName": "Tetrahydrocortisone"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Life Sci. 1994;55(11):863-72", "ArticleIdList": ["8072387"]}, {"Citation": "J Endocrinol Invest. 1989 May;12(5):303-6", "ArticleIdList": ["2549114"]}, {"Citation": "J Clin Endocrinol Metab. 1986 Sep;63(3):550-7", "ArticleIdList": ["3460996"]}, {"Citation": "Hypertension. 1995 Jan;25(1):67-70", "ArticleIdList": ["7843756"]}, {"Citation": "J Chromatogr. 1988 Dec 2;456(1):71-81", "ArticleIdList": ["3243872"]}, {"Citation": "J Clin Endocrinol Metab. 1987 Jul;65(1):101-4", "ArticleIdList": ["3034947"]}, {"Citation": "J Clin Endocrinol Metab. 1995 Nov;80(11):3145-50", "ArticleIdList": ["7593417"]}, {"Citation": "Am J Physiol. 1985 Mar;248(3 Pt 1):E388-90", "ArticleIdList": ["3156509"]}, {"Citation": "Science. 1988 Oct 28;242(4878):583-5", "ArticleIdList": ["2845584"]}, {"Citation": "Steroids. 1993 Dec;58(12):611-3", "ArticleIdList": ["8116017"]}, {"Citation": "Lancet. 1988 Oct 29;2(8618):986-9", "ArticleIdList": ["2902493"]}, {"Citation": "Circ Res. 1980 Jun;46(6 Pt 2):I94-100", "ArticleIdList": ["6991154"]}, {"Citation": "Steroids. 1990 Feb;55(2):52-8", "ArticleIdList": ["2326827"]}, {"Citation": "Lancet. 1987 Oct 10;2(8563):821-4", "ArticleIdList": ["2889032"]}, {"Citation": "Lancet. 1950 Sep 23;2(6630):381-6", "ArticleIdList": ["14785168"]}, {"Citation": "Endocrinology. 1975 Jul;97(1):46-51", "ArticleIdList": ["166832"]}, {"Citation": "Clin Endocrinol (Oxf). 1983 Nov;19(5):609-12", "ArticleIdList": ["6315264"]}, {"Citation": "Steroids. 1984 Nov;44(5):383-417", "ArticleIdList": ["6399959"]}, {"Citation": "Endocrinology. 1982 Nov;111(5):1683-6", "ArticleIdList": ["6290195"]}, {"Citation": "N Engl J Med. 1991 Oct 24;325(17):1223-7", "ArticleIdList": ["1922210"]}], "ReferenceList": []}], "History": [{"Year": "1996", "Month": "10", "Day": "1"}, {"Year": "1996", "Month": "10", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8957748", "10.1007/BF03349029"]}}]}